FAP-targeting peptides

Novartis strikes $425M deal with 3BP for FAP-targeting peptide technology
Medical Marketing and Media
Tue, 04/25/23 - 10:32 am
Novartis
3B Pharmaceuticals
FAP-targeting peptides